This site is intended for healthcare professionals

FDA approves Tecentriq + Cotellic + Zelboraf to treat of BRAF V600 mutation-positive advanced melanoma patients.- Genentech/Roche

Read time: 1 mins
Last updated:3rd Aug 2020
Published:1st Aug 2020
Condition: Metastatic Melanoma
Type: drug
Register for free exclusive healthcare eLearning resources

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest